A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan

20233 citationsJournal Articlegold Open Access

Authors

Nolan M. Winicki · National Institute on Aging

Alay Nanavati · National Institute on Aging

Christopher H. Morrell · National Institute on Aging

Jack M. Moen · National Institute on Aging

Jessie Axsom · National Institute on Aging

Melissa Krawczyk · National Institute on Aging

Natalia Petrashevskaya

Abstract

Administration of ARA290 reduces cell and tissue inflammation, mitigates structural and functional changes within the cardiovascular system leading to amelioration of frailty and preserved healthspan.

Topics & Keywords

Erythropoietin and Anemia Treatment Frailty in Older Adults GDF15 and Related Biomarkers

Publication Details

Published in: Frontiers in Cardiovascular Medicine

Volume 9, pp. 1096887-1096887

DOI: 10.3389/fcvm.2022.1096887

Field-Weighted Citation Impact: 0.90

Command Palette

A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan

Authors

Abstract

Topics & Keywords

Publication Details